Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 220 of the 220 references it cites were found in a registry or an index; 34 of the 249 sources its claims cite were checked for support.

Paracetamol (acetaminophen) overdose and hepatotoxicity: mechanism, treatment, prevention measures, and estimates of burden of disease

Open access
Chidiac, Annabelle S, Buckley, Nicholas A, Noghrehchi, Firouzeh, Cairns, Rose · 2023 · Expert Opinion on Drug Metabolism & Toxicology

Abstract

INTRODUCTION: Paracetamol is one of the most used medicines worldwide and is the most common important poisoning in high-income countries. In overdose, paracetamol causes dose-dependent hepatotoxicity. Acetylcysteine is an effective antidote, however despite its use hepatotoxicity and many deaths still occur. AREAS COVERED: This review summarizes paracetamol overdose and toxicity (including mechanisms, risk factors, risk assessment, and treatment). In addition, we summarize the epidemiology of paracetamol overdose worldwide. A literature search on PubMed for poisoning epidemiology and mortality from 1 January 2017 to 26 October 2022 was performed to estimate rates of paracetamol overdose, liver injury, and deaths worldwide. EXPERT OPINION: Paracetamol is widely available and yet is substantially more toxic than other analgesics available without prescription. Where data were available, we estimate that paracetamol is involved in 6% of poisonings, 56% of severe acute liver injury and acute liver failure, and 7% of drug-induced liver injury. These estimates are limited by lack of available data from many countries, particularly in Asia, South America, and Africa. Harm reduction from paracetamol is possible through better identification of high-risk overdoses, and better treatment regimens. Large overdoses and those involving modified-release paracetamol are high-risk and can be targeted through legislative change.

Overview

CoChat Summary

TL;DR

This review summarizes paracetamol overdose mechanisms, risk factors, risk assessment, treatment, prevention measures, and global epidemiology. It estimates that paracetamol is involved in 6% of poisonings, 56% of severe acute liver injury/acute liver failure, and 7% of drug-induced liver injury, with about 0.4% of paracetamol poisoning cases fatal.

Key findings

  • Where data were available, paracetamol accounted for a weighted mean of 6.2% of poisonings (range 0.5–34.9%), 55.7% of severe acute liver injury and/or acute liver failure (range 50.0–77.8%), and 7.3% of drug-induced liver injury (range 1.2–29.2%); the case fatality rate for paracetamol poisonings was 0.4% (range 0.1–2.3%).
  • Toxicity occurs via NAPQI, formed primarily by CYP2E1 and CYP3A4; when glutathione is depleted, NAPQI binds cellular proteins, causes mitochondrial dysfunction, and leads to hepatocyte necrosis. Acetylcysteine replenishes glutathione and is most effective when given within 8 h of ingestion.
  • Major risk factors include massive overdoses (>30 g), modified-release/extended-release paracetamol, delayed presentation, enzyme inducers, malnutrition/fasting, and chronic alcohol use; repeated supratherapeutic ingestion carried higher hepatotoxicity in one US study (52% accidental vs 14% deliberate overdose).
  • Prevention evidence includes UK 1998 pack-size restrictions, associated with a 22% reduction in suicidal deaths in the first year sustained for two years, ~30% reductions in liver unit admissions and liver transplants, and a 20% reduction in large overdoses; Denmark’s age and pack-size restrictions reduced poisonings and severity, while early evaluation of Australia’s modified-release up-scheduling found no reduction in MR paracetamol poisonings.

Methods

  • Narrative review with two literature searches: a PubMed search for poisoning epidemiology and mortality from 1 January 2017 to 26 October 2022, plus poisons information centre annual reports and email responses; and PubMed/Embase searches from inception to December 2022 for clinical toxicology topics including risk assessment, risk factors, management, and legislative change.
  • Epidemiology analysis included 115 data sources: 88 relevant publications, 17 annual reports or statistical information from websites, and data from 10 email responses; weighted averages were calculated using meta-analysis in R 4.0.4, with rates expressed per 100,000 population and/or as a percentage of poisoning exposures where catchment populations were available.
  • Case fatality rates were calculated where possible by dividing cause-specific poisoning fatalities by exposures; for clinical sections, the authors used keyword searches, systematic reviews, and citation chaining.

Limitations

  • Stated: the PubMed-only search may have missed relevant studies; data were lacking from many countries, particularly in Asia, South America, and Africa; only 11 direct PIC email responses were received, 66 emails were undeliverable, and over 50 websites were inaccessible; definitions for analgesics, DILI, and ALF/ALI were inconsistent; PIC operational models varied; catchment populations were often unavailable; some data covered only certain regions; death data sources have limitations, including missed out-of-hospital deaths and possible over-counting by coronial/forensic data in multi-drug overdoses; pediatric-only data sources were excluded.
  • Evident from the text: this is a narrative review rather than a systematic review, and the global estimates rely on heterogeneous observational data and weighted means that may not be internationally representative; no formal risk-of-bias assessment is reported, and several intervention evaluations are observational or lack published outcome data, such as the impact of the EMA suspending modified-release paracetamol.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1080/17425255.2023.2223959

Cites

220 of 220 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Image 1
CC-BY-NC-ND · From the PDF
Image 2
CC-BY-NC-ND · From the PDF
Image 3
CC-BY-NC-ND · From the PDF
Image 4
CC-BY-NC-ND · From the PDF
Figure 2 Toxic mechanism of paracetamol and mechanism of action of acetylcysteine. Paracetamol is primarily detoxified by glucuronide and sulfate conjugates which are then excreted in the urine. A small percentage is metabolized by CYP2E1 to the reactive intermediate NAPQI. Under normal conditions, NAPQI can be detoxified by reaction with glutathione to form cysteine and mercaptopuric acid conjugates. If glutathione is depleted (e.g. in paracetamol overdose), NAPQI binds to cell macromolecules causing hepatocyte cell death. The antidote acetylcysteine replenishes cysteine, which is the rate-limiting factor for glutathione synthesis.
Figure 2 Toxic mechanism of paracetamol and mechanism of action of acetylcysteine. Paracetamol is primarily detoxified by glucuronide and sulfate conjugates which are then excreted in the urine. A small percentage is metabolized by CYP2E1 to the reactive intermediate NAPQI. Under normal conditions, NAPQI can be detoxified by reaction with glutathione to form cysteine and mercaptopuric acid conjugates. If glutathione is depleted (e.g. in paracetamol overdose), NAPQI binds to cell macromolecules causing hepatocyte cell death. The antidote acetylcysteine replenishes cysteine, which is the rate-limiting factor for glutathione synthesis.CC-BY-NC-ND · From the PDF
Figure 3 Percentage of poisonings relating to paracetamol. Dark blue points represent data from a single hospital/treatment center, light blue points repre­ sent data from multiple hospitals/treatment centers or large administrative databases, while orange points represent poisons information center data. Dotted line shows weighted mean across sources 6.2%.
Figure 3 Percentage of poisonings relating to paracetamol. Dark blue points represent data from a single hospital/treatment center, light blue points repre­ sent data from multiple hospitals/treatment centers or large administrative databases, while orange points represent poisons information center data. Dotted line shows weighted mean across sources 6.2%.CC-BY-NC-ND · From the PDF
Figure 4 Percentage of poisonings caused by intentional ingestion of parace­ tamol. Dark blue points represent data from a single hospital/treatment center, light blue points represent data from multiple hospitals/treatment centers or large administrative databases, while orange points represent poisons informa­
Figure 4 Percentage of poisonings caused by intentional ingestion of parace­ tamol. Dark blue points represent data from a single hospital/treatment center, light blue points represent data from multiple hospitals/treatment centers or large administrative databases, while orange points represent poisons informa­CC-BY-NC-ND · From the PDF
Figure 5 Paracetamol poisonings per 100,000 population per year. Dark blue points represent data from a single hospital/treatment center, light blue points represent data from multiple hospitals/treatment centers or large administrative databases, while orange points represent poisons information center data.
Figure 5 Paracetamol poisonings per 100,000 population per year. Dark blue points represent data from a single hospital/treatment center, light blue points represent data from multiple hospitals/treatment centers or large administrative databases, while orange points represent poisons information center data.CC-BY-NC-ND · From the PDF
Figure 6 Intentional paracetamol poisonings per 100,000 population per year. Dark blue points represent data from a single hospital/treatment center, light blue points represent data from multiple hospitals/treatment centers or large administrative databases, while orange points represent poisons information center data. Dotted line shows weighted mean across all sources: 5.4/100,000.
Figure 6 Intentional paracetamol poisonings per 100,000 population per year. Dark blue points represent data from a single hospital/treatment center, light blue points represent data from multiple hospitals/treatment centers or large administrative databases, while orange points represent poisons information center data. Dotted line shows weighted mean across all sources: 5.4/100,000.CC-BY-NC-ND · From the PDF
Figure 8 Deaths attributable to paracetamol poisonings per 100,000 population per year. Dark blue points represent data from a single hospital/treatment center, light blue points represent data from multiple hospitals/treatment centers or large administrative databases, orange points represent poisons information center data, purple points represent coronial/forensic databases. Dotted line shows weighted mean across all sources: 0.04/100,000.
Figure 8 Deaths attributable to paracetamol poisonings per 100,000 population per year. Dark blue points represent data from a single hospital/treatment center, light blue points represent data from multiple hospitals/treatment centers or large administrative databases, orange points represent poisons information center data, purple points represent coronial/forensic databases. Dotted line shows weighted mean across all sources: 0.04/100,000.CC-BY-NC-ND · From the PDF
Figure 7 Proportion of patients who develop ALI/ALF or DILI after paracetamol use. Dark blue points represent data from a single hospital/treatment center and light blue points represent data from multiple hospitals/treatment centers or large administrative databases. Dotted (ALI/ALF) and dashed (DILI) lines show weighted mean across all sources: ALI/ALF = 55.7%, DILI = 7.3%.
Figure 7 Proportion of patients who develop ALI/ALF or DILI after paracetamol use. Dark blue points represent data from a single hospital/treatment center and light blue points represent data from multiple hospitals/treatment centers or large administrative databases. Dotted (ALI/ALF) and dashed (DILI) lines show weighted mean across all sources: ALI/ALF = 55.7%, DILI = 7.3%.CC-BY-NC-ND · From the PDF

Verification

Claims the paper makes

17 Valid · 2 Not valid · 114 Not checked · 49 Own results and interpretations

82 more claims · 7 with their cited sources checked

Create a free account to see all 182 claims and to verify the 215 references still open.

See all claims — free account
  • It may state two separate claims as one. 58
  • Probably not a substantial claim. 50

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 220 references

Research works printed but not linked: 14

  1. 2021, WHO model list of essential medicines - 22nd list, 2021
  2. Cahn A, 1886, Centralbl Klin Med, 7, 561
  3. von Mering J, 1893, Ther Monatsch, 7, 577
  4. Brodie BB, 1949, J Pharmacol Exp Ther, 97, 58
  5. Afandiyev I, 2019, Georgian Med News, 287, 105
  6. Bentur Y, 2019, Isr Med Assoc J, 21, 175
  7. Babić Ž, 2022, Arh Hig Rada Toksikol, 73, 88
  8. Boletim CIAV, Centro de Informação Antivenenos Dados Estatísticos 2021 [CIAV Bulletin – Antivenom Information Center Statistical Data 2021]
  9. Kumpula EK, 2021, N Z Med J, 134, 26
  10. Khan M, 2019, J Pak Med Assoc, 69, 1025
  11. Supervía Caparrós A, 2017, Emergencias, 29, 335
  12. Nugteren-van Lonkhuyzen JJ, 2022, [Acute poisonings in humans and animals - NVIC Annual Review 2021]
  13. Poisons Standard October 2022, 2022, Canberra
  14. 1.4. Final decision in relation to paracetamol (modified release) [Internet]

Cited by

See all 253

Metadata

Authors
Chidiac, A. S., Buckley, N. A., Noghrehchi, F., & Cairns, R.
Affiliations
The University of Sydney (AU)
Corresponding author
Cairns, Rose
Venue
Expert Opinion on Drug Metabolism & Toxicology
Published
2023-05-04
Volume
19
Issue
5
Pages
297-317
ISSN
  • 1742-5255 (ISSN-L)
  • 1744-7607
OpenAlex
W4384074050
Cited by
215
References
220
Citations by year
2026: 85 · 2025: 76 · 2024: 48 · 2023: 5
FWCI
9.89
Type
journal article
Language
en
Open access
Locations
  • Expert Opinion on Drug Metabolism & Toxicology (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Figshare (submittedVersion, cc-by)
  • Figshare (cc-by)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
  • Health Sciences › Medicine › Emergency Medicine › Poisoning and overdose treatments
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
Keywords
acetaminophen overdose, paracetamol, hepatotoxicity, acute liver failure, drug-induced liver injury, N-acetylcysteine, antidote therapy, poisoning epidemiology, drug overdose deaths, harm reduction, over-the-counter analgesics, drug regulation
MeSH terms
Acetaminophen, Acetylcysteine, Humans, Cost of Illness, Chemical and Drug Induced Liver Injury, Drug Overdose

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-04, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-04 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Paracetamol (acetaminophen) overdose and hepatotoxicity: mechanism, treatment, prevention measures, and estimates of burden of disease. https://app.cochat.ai/papers/10.1080/17425255.2023.2223959
The paper
Chidiac, A. S., Buckley, N. A., Noghrehchi, F., & Cairns, R. (2023). Paracetamol (acetaminophen) overdose and hepatotoxicity: mechanism, treatment, prevention measures, and estimates of burden of disease. Expert Opinion on Drug Metabolism & Toxicology. https://doi.org/10.1080/17425255.2023.2223959

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.